Furthermore, background alterations in CDH1-carriers make it even more difficult to discover cancer lesions: Chronic gastritis, foveolar hyperplasia, cystic gland dilatation and epithelial tufting, as well as globoid change, have been described in CDH1-carriers [48]. This evidence concerns the gene CDH1 and chronic gastritis.